[
  {
    "request": {
      "base_url": "https://openrouter.ai/api/v1",
      "model": "openai/gpt-5-mini",
      "messages": [
        {
          "role": "user",
          "content": "A 20-year-old African American woman came to the clinic with a complaint of persistent fatigue and unintentional weight loss. She has a mole on her back that has been darkening and increasing in size over the past few months. It has an irregular border and is now slightly raised. She noticed a new, dark spots on her arms and chest, which weren't there before. She reports a recent dull ache in her right hip, shortness of breath, and chest discomfort. She has felt increasing fatigue and noticed swelling in her legs and abdomen. Physical exam reveals muffled heart sounds and jugular venous distention. Fluid analyses after pericardiocentesis reveal malignant cells, high protein and LDH level. What is the next best step in the management of this patient? \n\n\nAnswer Choices:\nA. Prescribe meloxicam to manage the persistent fatigue \nB. Prescribe low-dose analgesia \nC. None of the choices\nD. Chemotherapy to kill the malignant cells \nE. Immunosuppression \nF. Rapid antibiotic infusion\nG. Radiotherapy to treat the malignant cells. \nH. Diuretics to reduce the fluid overload "
        }
      ],
      "reasoning_effort": "medium",
      "response_format": {
        "type": "json_schema",
        "json_schema": {
          "name": "answer",
          "strict": true,
          "schema": {
            "type": "object",
            "properties": {
              "answer": {
                "type": "string"
              },
              "answer_letter": {
                "type": "string",
                "enum": [
                  "A",
                  "B",
                  "C",
                  "D",
                  "E",
                  "F",
                  "G",
                  "H"
                ]
              }
            },
            "required": [
              "answer",
              "answer_letter"
            ],
            "additionalProperties": false
          }
        }
      },
      "usage": {
        "include": true
      }
    },
    "response": {
      "id": "gen-1762208490-Zh3peqO68JXXbjR2lYR1",
      "choices": [
        {
          "finish_reason": "stop",
          "index": 0,
          "logprobs": null,
          "message": {
            "content": "{\"answer\":\"D. Chemotherapy to kill the malignant cells.\\n\\nThis presentation is metastatic melanoma with malignant pericardial effusion causing tamponade (muffled heart sounds, JVD; pericardiocentesis with malignant cells and exudative fluid). After urgent drainage, the next step is treatment of the underlying malignancy with systemic antineoplastic therapy. (In contemporary practice metastatic melanoma is most often managed with systemic therapy such as immune checkpoint inhibitors or targeted therapy when indicated; among the provided options, chemotherapy/systemic antineoplastic treatment is the correct choice.)\",\"answer_letter\":\"D\"}",
            "refusal": null,
            "role": "assistant",
            "annotations": null,
            "audio": null,
            "function_call": null,
            "tool_calls": null,
            "reasoning": null,
            "reasoning_details": [
              {
                "type": "reasoning.encrypted",
                "data": "gAAAAABpCSr6hl_yzeeBGvrI_9KtmaHNkPVoRFxb7nQc1OruRY4b-4B6afAKNZKpMtSDZ8mykoVEauXAJki_IB3Xu-i9SNiYjHntE8rmdbjPv7Vr9fi5aCkU0uswj_iyin7PuUiEbfrZdXjEHq1mdW-FwXiGNJpivpNfDX6PP9EQU2bN-FoBpEWUg-vuM8ddtX6hwtf7GkHTyYGIrOeZetHCIT-0VFUwoZI1wRn0TCMxk4itJisLzhx89SjSZE9kqWtbbg_GJ_wAMSc1SYPTAwi13PWTTO95VGX5_XtbF_2wrNeUhqlxORrgWue1nwd5PJ6ZCFWRQB8BkE1CF3hp5T16oTQLMelXOTdpVlV1KY4VQGY8SVVWoXigVkrMmUrDdTQ-dIxgNJVluDctddJL1EGDFQhMHZkOuQUDC56o_AoBnJ0Ucm8yNPeAwOcvorbYHihauph9jWH4E6Wi4KXZ3rsxV958SIWVMx6LDqtRpZyu-6ZVvmWKoS3B3m-28swj4hpbEUgIAasL7S2YijI0bKX25DjMPIjra0_dozpJPEOsJrxeXfhihCTapmeZwS8_7RkSQh5EyGsxZIQEROuWf_2M4lVMgWHExwsRVQr1DdFv_u2uMWJoK3ShGPvq5wOoCZJjm9VuxGuVoXgVr3TSW5vC3Pizt8X3cx2vGxH_MP-eeXs7gVtmNjOsRtmmTwa5qkNKwQvXAtz-tRoK3web0_s0QvnhTFzO6t-2mGsEAN5tOLaXlwwkQfpjhlzJYgiYekLLfoPZ-qG_Uud48oNb3mzTaUgNCR3_iWVOZK7wVOtzL-erf7O2MKjP6rkF2vTUKEEqfQ7b0FBsJHY0jAhr0yupJms5TpevnGUj6OJPRGIA92bL0XkBH5gMWe2LXEXXhCgaaRvP-B7tAbkiqNmGN0EbwVtdNRBOlfukIVSkNCNi6e_b1HsIw82d4BSddl7H7PIqmAhJxVqSHxPQC5DyzRGQRw5Kh-orrjjUEssLUCcFnZiNM0P0CJS9jCVrmzh-Ss2e4CY7mz9Ar0a1rPShP-3nSxUS4ikH19NFsf6WuD1_CLV_6Di-ebACHtXVzjyoQnPRXe_p-aOG74WV6fIDVWouodWpRwL0RVhBWG6hPf4GjKHuU_RxQb6FZgs1EcWcJidTYpvpdyHJicsTKjFbkemjAeFWKcjKXMnPQW1HiPTbmrMEbtxYq8a2qS-1gahNBw4YibnmpvlFAInM5wtSCm9Vgv8M4SvJscdisWuEOtgEjmrfwuD3_13DkriLPsCWkDWm693eJoRGQ1DpN72eMNW1oRtgraSu2PXqVWefsoM5oLAWc3OkvNmUrBMpMm8WHslbtuxGjj1NvStU9dAujiuQCulJAsJNcgU6BhIwH8-fQKL64wGjamCwWvW2sDyNIM22Xeitjxm4vmOX0LFt7qkaVermkYWBtb0bJjC-Yy7lXzKDQHv5v5yducZBLn9x0qoR5PfNsdSUp5gOGwwM4n1j40id-ZhZFjoQJ1PxZw6RHzWP8eRsK6PqmX9iZUoNJyD9kwI7sIWp4fL4AVXYxmIW27xjvDoPgKkFTZPATSax_xH48ZMqiXVGHp1esGZlk0sX5iP7PDWZzdwgz2S8SBAlil8VFDhTvnxn7QOPK1SQM_aGrk2ksJTCt3JazSakjcAgwrWQ5ST-Ous0-zOuuV6MkndjCy3Mbgr6UCMVQGSOu3OFdpiqZeUUxZalM56QEOi1ECY43x20QsOb3_L9BqDPi0ljCVs-t6KoUD05rZiYrIAo_7lF_gGU4f-mqfewOtfCFMZRnig331WIpD5JkEMF4z9ApNd5ORm4aRBJJdXfdoHFshVGLC84MUU9QCpvUNJjOugS9JuGQt9EGke9MLBYSCjLL_gFCDRO8QmqoZsyIhCX2W24SP5rPzR_5KxWYua4SRzuauCKLuD5TYRKakxk3ba7Un-CJMFJSrdF_a8Df5ubdkpSnkKOjXhDjTA67K9cQOqIpIxLUu99oP7VHSyC7WRlEJG_0uZJeM3nk8l83pvfQNIix53Ejeci93Yjz3O6qkgmMzZV7_lYC0ltquaDQhOfxdrz4rnsIUXlFY45VYxeuU52kKTPTj40nTEx5kHfjPFI8QYll_GSxhFLe38RrqeYCCNvLFtgHh_adQAt91luawxE_c1N895gziMyqL5cbT1JIEb77_asFhHjkXBkA52ZmwCLhH7cTaVT3ulTbY9Cyohk5WxVZghcetJrmjV3NGoiW1BRmrh1vIY0Uzhw6Z4sRwQ1U2nLbTEnYEZaXklChDwqTHiopWBuarRqcX-cO1lEZTv5Rc1HjliGTNTzuTGSVDebU8U3K872uOT4x6bVYQeuDMhVr3LgQb2j2moTY4y-7hV6yRXHM57V9sN-m5HqGL2BJauX8RGslPUfD6fKgliWj7m2PbtmbgP8tamVhUjSC6crRMrLDe2wd6hSUD3sNf5dWxJ8OkelNee9OBQpj1DAND6gRApwJkW1ZEj70gF9OCZXvEtN6aadeuL5qKxJ1TK8YTsH9qX1hhqnX-6BdvC7DQ-EcJzS6x9xsiRK5gcHynBLWSc92mBxO-1x1_6h8ZLy0HiSzYRwwU9eovRzU8lBRPThWfY0QSD-DoK19VvsgGQOAWI6iw3SOhiiuFexGQ-4XbbbofLjBA85r1rLorXRPU3T-L2k0hejZSSMzYR9k3U8OjFVIMzuwHfin9cIGThhUX_HSm7PeFwAdvDqz-n1_YhUnbTqQyLphOLy0le6a2QJuyoEz6sNOLttjtbOCNDIlfkKyUPMy40BTLW5sjARlMDnNIvLaIEje46RSy4WlrWbY9WAGb5MTiirZZ3Nz6D41TlgAdNvrdOcqsISutgUOyNyxdXzg4Sr10-tmssdheCwlhrpQPHPnBJGuIOGfl7KkX42EWFNJAkcnqviGbRbGMtSOli4M-2CpHz7T3VRvLi-fYgVWgUD2EJHFDDsVTFiLCGcDzqCNjPZ_t6aEtVrveldYIt0O-003YfMeihhC0Sk68IuRLWI80Hf1PFLwS3Yn6yzJlqrzbCuLCNEnljqnOO1JghN6DcdMyh1fPyFeYEjpB3upNH3oltXYUL9Fm18SHppNvd6IEgwX-IIIR35ZIgrFsBsNFHdzP0KYIhQO3xTvngniU7Nu_MkdJmm1u3FeA-hrrLyUFNloFAgwOtNKHWr7xHBAkmh5C_J9ZVdLbB0rZqrMcqManF-IHsdu24wJTuVTYf57c5Z0fzzk9VfVgrtWIc4iiU-b7oCcmcIrT_Q1zrYSs8yf_AUyQRnc1b-NkWaLd0KNLAxYBcixbNTpZDTNNlKi97kruP86E3seZ8GWB0paO6UKYl81D8_JWF7gd0vpIEU-hKPeBHrFrmoYY1FUzD5TuHci75ROrqYt2i0NNFfJEExf_mC5c6MaX8enSZ4PZb15jnIdzHykrgy4VRgIB3JSK4lvzwKYpkujMkOCi0Y8ncLgu7w9dxodrRzdftXtRKnkIuOy4_GSC5RIzwXsUWAn6qrQG4IpWrRe7jdw2mWYu2jPzwVRaT8xBLGWJwMMS1_T_jY261c4GBZawPHsxTyzpjgeRl3CWvIyqylAU0ElahUlwe_DqAVMEJXu8XRiz7AaNItokv9yaRNfvTA-6KOBE7-kF0hxCyU7z5n1n7Qs_DbsAd0c_LWxKHB0ElT7hEBLqBWzXloVXHMY3yWB2-Rqq58pjyuvYXsz4Ee5QpXYdisLEcG8JBmcd19A53fEGGnkwt1BCPRoCYV_vrAXR7k44FDYquo_NyxMBCsLhHpRfjW6Qw_eGAeZJRP2yUZakX-3lI3J549J8_u0i9jXTteelvkUjn_aKDGVnvGXpCf0IeiPBDSD5ZV7Kx391sjHtmYzJQxVPd7Uh5hGdo-QK-0xAyRJZos43DRS-Xrg-uEzPaXkz2582TdR-cSEYf1QCzZs9GwfIR5M6LjbIuspWha8Ko0C_boZCkfCC33bUN2VBzAymvcx_yAZTVn14YCHGh0yDnq4-5ZtFDpl-X8n1ci0im8EmBlqQVijjoI2O-tWetF3Mj2c35ZxTi3R421zcgyO8BOgO0zD45QJkkcoTXHQ6peyABYuBiegDmJ8mIWDS6BRDRd6_bC964OJMT1gX3RQhj2iMBwiczkPMToxwOP5e0IpPVS2V-E8coMxg7UjzLQ5ijpmVfjFeden7DN7xbRnBE-wz0u8fN-h_NwLAZZiyEnAb2QPmPxuJkxsff5G-Yzf_VtQUHFnCF6Ns_p_3dbA6bkr-cGj6ippv_7_mzU0U1xOyhH8e2ZJa32-lVdLkX_lRHZatde8-CDfDkt3j39nCPW7GbacATPof5dlqQ8jD25uc88pfkDHJWFEhEqeGaBbo0v8BpHLkRXQVDM7j-iRs1Ym0ghv3hfepNX60S1xlWGt4lKFlK8QYtkcRGvJMVfVqUNqZ1IHxDb-8gDRQlt5r2aXY1qLEbt42mYYcjvltlaXhZNhCea063dPKdbgnz3_tBixxpEbSfjFaVGxqQC5gGeGD2b1GP0EsaYqMp2iub91IG24dkfDgOLWi8cLq6TcmgvedJ88oVjFbBdkiKW8n1E70GyhfnwZ3KiuYxvcFUOCS0huewk7xdUsIlcyyoXC3AEbVwmq_g8-BGMd0SMF9h7JiFSAxN9GQLKFH1XjXx6lLagPdKj9icG-fjbfuEXCjuLEutZA809EwUR0If9lg2zvdYKXHtDcXC0U36MsL78GNQdH3OnAkWQWiWPENUbB3CRePDNVPgrsoTV8XrwBsfYj7jxCST1VPzy-xxkMw-ZiQJgfZQVzFBcHLprWLuo3YcUYYm48z59plDNbCNNWucyPYDIUAhbg5DoPMkwRKsZhtAGWQ30Is2Wzu-Gv7aziBfQYyySkJUXyhB8S9ZIbY4_MbIhFUr6l1i-KB3rLdVMw5uggvnxhOo5QJbWjJx3iKiK4PSbom9LcNiyqehqHH1_5y_Jn-mlPxJJiQ79RI7IyD84OApkrlYAHezyh5fYOGvCFRZNhK6JZHxdFYcXzTjM_utxWARKEO-nzrlo_j6zIntPVyk6TyCOHY_UZPPZqaB-Z40gS7F6evQfGAwtTvAPn4fxO81LxLq3QOlsySSyVDG-VPDudxNl-lp-J0eFNSZCUvE92jwuNSS5-IJSxio1dOeNcuCoBJeR-rgtz8qZ0TjXi5_yCr4sCdYpVBB3neHiDrUkWyTGrTqKmTaPf2HkU2XNws2EeGs=",
                "id": "rs_0e262ba1e75f64e80169092aeb190c819091275ed7cb514600",
                "format": "openai-responses-v1",
                "index": 0
              }
            ]
          },
          "native_finish_reason": "completed"
        }
      ],
      "created": 1762208490,
      "model": "openai/gpt-5-mini",
      "object": "chat.completion",
      "service_tier": null,
      "system_fingerprint": null,
      "usage": {
        "completion_tokens": 836,
        "prompt_tokens": 290,
        "total_tokens": 1126,
        "completion_tokens_details": {
          "accepted_prediction_tokens": null,
          "audio_tokens": null,
          "reasoning_tokens": 704,
          "rejected_prediction_tokens": null,
          "image_tokens": 0
        },
        "prompt_tokens_details": {
          "audio_tokens": 0,
          "cached_tokens": 0
        },
        "cost": 0.0017445,
        "is_byok": false,
        "cost_details": {
          "upstream_inference_cost": null,
          "upstream_inference_prompt_cost": 7.25e-05,
          "upstream_inference_completions_cost": 0.001672
        }
      },
      "provider": "OpenAI"
    }
  },
  {
    "request": {
      "base_url": "https://openrouter.ai/api/v1",
      "model": "openai/gpt-5-mini",
      "messages": [
        {
          "role": "user",
          "content": "A 20-year-old African American woman came to the clinic with a complaint of persistent fatigue and unintentional weight loss. She has a mole on her back that has been darkening and increasing in size over the past few months. It has an irregular border and is now slightly raised. She noticed a new, dark spots on her arms and chest, which weren't there before. She reports a recent dull ache in her right hip, shortness of breath, and chest discomfort. She has felt increasing fatigue and noticed swelling in her legs and abdomen. Physical exam reveals muffled heart sounds and jugular venous distention. Fluid analyses after pericardiocentesis reveal malignant cells, high protein and LDH level. What is the next best step in the management of this patient? \n\n\nAnswer Choices:\nA. Prescribe meloxicam to manage the persistent fatigue \nB. Prescribe low-dose analgesia \nC. None of the choices\nD. Chemotherapy to kill the malignant cells \nE. Immunosuppression \nF. Rapid antibiotic infusion\nG. Radiotherapy to treat the malignant cells. \nH. Diuretics to reduce the fluid overload "
        }
      ],
      "reasoning_effort": "medium",
      "response_format": {
        "type": "json_schema",
        "json_schema": {
          "name": "answer",
          "strict": true,
          "schema": {
            "type": "object",
            "properties": {
              "answer": {
                "type": "string"
              },
              "answer_letter": {
                "type": "string",
                "enum": [
                  "A",
                  "B",
                  "C",
                  "D",
                  "E",
                  "F",
                  "G",
                  "H"
                ]
              }
            },
            "required": [
              "answer",
              "answer_letter"
            ],
            "additionalProperties": false
          }
        }
      },
      "usage": {
        "include": true
      }
    },
    "response": {
      "id": "gen-1762208490-CttjlVnFWQd0dqM1VfKy",
      "choices": [
        {
          "finish_reason": "stop",
          "index": 0,
          "logprobs": null,
          "message": {
            "content": "{\"answer\":\"D. Chemotherapy to kill the malignant cells\\n\\nReason: The pericardial effusion contains malignant cells consistent with metastatic melanoma causing malignant pericardial effusion/tamponade. After emergent pericardiocentesis, the next step is treatment of the underlying malignancy (systemic therapy). Of the choices given, chemotherapy (or, more appropriately for melanoma today, systemic anti\u2011tumor therapy such as immunotherapy or targeted therapy when indicated) is the correct approach. Other options (diuretics, antibiotics, immunosuppression, analgesics, or radiotherapy) are not appropriate primary treatments in this setting; radiotherapy is generally of limited value for melanoma and would not address systemic disease.\",\"answer_letter\":\"D\"}",
            "refusal": null,
            "role": "assistant",
            "annotations": null,
            "audio": null,
            "function_call": null,
            "tool_calls": null,
            "reasoning": "**Explaining treatment for pericardial effusion**\n\nI'm outlining the reasoning behind treating malignant pericardial effusion caused by metastatic melanoma. The key is to treat the underlying malignancy with systemic therapy, focusing on chemotherapy as options are limited, especially since immunotherapy isn't listed. I'll note that an emergent pericardiocentesis has been performed, and diuretics or radiotherapy aren't appropriate in this case. Lastly, I'll mention potential local therapies like a pericardial window for recurrence and appropriate systemic options for melanoma.",
            "reasoning_details": [
              {
                "type": "reasoning.summary",
                "summary": "**Explaining treatment for pericardial effusion**\n\nI'm outlining the reasoning behind treating malignant pericardial effusion caused by metastatic melanoma. The key is to treat the underlying malignancy with systemic therapy, focusing on chemotherapy as options are limited, especially since immunotherapy isn't listed. I'll note that an emergent pericardiocentesis has been performed, and diuretics or radiotherapy aren't appropriate in this case. Lastly, I'll mention potential local therapies like a pericardial window for recurrence and appropriate systemic options for melanoma.",
                "format": "openai-responses-v1",
                "index": 0
              },
              {
                "type": "reasoning.encrypted",
                "data": "gAAAAABpCSr58siAOvGc-ENkqL009ApV6Leg7DdQe3Rd0KWaoruuPmG4Z0wEW_QrmZB-5kZLlcUqdKklSTPDGGk-uMjksobntQ47M4E9mFl8OR3P5iOTG6c5a_7dOGL8AdlukUAfxM1RwzP9P1XtOZt0I-9kUXBThY9UG3dghwYGu1dyt0rQSwphNvLfYYECclAT9aTZ6s0WZSEs0qx1iAGXzbr8sYhdjUpyCUD0tEb0tyg40FZGRGudEOTOcYzwkSYSYFVMLqvE-QjfoVC4p_DUBEdYx86fi8-G-eYdVod7NpVOLzc1U-pSAbZyac1xSUkGxa3DAGjoUtElV7BhtfwEP7z821GFSRY-rELzvUDpR4X6iXfbmgUJctd5oCmr5PiVopIExKNHTB4ulWwEW69LPgxE84xcoXY47-Y-NlVj7JU-Vljnhc7EV0o05hMm875pNng_rKgJTCKvgD-LxnKRVqA7Pjyc1bo8QFD-fGpJYWLyElOnZmuRLVTIBWTJFUZ2tyRb9kZUBuWfp8Q1JdmyWA-IFlAHk3lCIaqgz5VYPbK4gTfwMhKHkn75zE19YElW9gf2gYrr11AALTNYxSLWH3ZyfkfDWe4YODVLOj-srpF7RYxdmAVLRqAAZVMQaVOUkD-QS9NYLQdE31IE-aDoydMhyp2wWRnCEoAu3ykuKLcJbXwjqqOjFJSNG8E-TY2arPyvZqB7F7jm6yoXIs_HskMTfBl8OkvEUz4XY5jByWnS8S4f89ODhMb26pT_KPBgubBvAISq78tzJkdZ8dzIdZlPgLMjINYgIRYxBAQjVQZduXYxU0pxMTGA8ctxKIeCf0mEm90fvHVJAcNhrASY68HJCuEkg8VhQD4SGABC9oAqPR1chkABrcWaVC107Q9r4shJ_btfUyRquYK3iIu4IARaQnM8h77ZSyiHgjMjgSGq2irNyG81fx_f-9yEvyl-A1kDOOm9fPmLFsRRCjNXQesPuZTLKoJoIQY8V-mGbmjpo6CPg2-TPsl8copDMKrMIH45NhBfNPmyacAfAul4Uyx5rn65qTcP0x2EmobtyOYEvJtXZVfoLUktHqs30YV_i08pqE9d1-yvz3FLxKtS4DInsskxegOfNlqfggBEa_8NrpgkScPk2V7Pm50AdED6wk6EKUW6NoeC2FaqxqWdqh6k0UsU7yY6n0-Vr1UxLMyFx-gyvpFsZd7VmLtPr1AXHp16p5wm20hKWblHMO1OPeefWypk2QBViS6xjVoSj4LJH8Lckv7JwrqXYdLmvrPctBRw-hl25-wPUdWZJlVbTNZZvWeaaNfkhAR-r_NOjxOOUmIr6yxyNijTyJK9YOFHK5NOKM0y1fTfAhPNaQHSUvwp_CS_QG8Bu_FSVu2pF5Vuye-6JnFojEW4lRseIHUlrlLqEDsuiEB3slvwMAc6U6DZKucFsGS3UWzGKB_9sebl7ObmYDZA6bPrXvyV22r9Z8LyvrpZxKWkkpTENU8KajRL4_7-0EbNHEyBdrGb4UFcSYgaC4g-8VV3dELuPUSQIpPp1n0or-kVNvyoWYCVmkAa3arJJCx8u2_ykAkomZPSYPxPFQVrmZIpR-urRLBafWlAFQrItceIxNKbMiFJlbEk-zbSWJJoAo7dxHdA9i7Dg3sbU46om_CQuCpM0tDccAo-M-NGKf690hBBKonSMImcYDvNTZ1fVsKlxe7tt0JMWnEW5j5NNvtnNwdN0Xlwd9zTEEwa4fyCTUihpDioxUlbk5T2MYI6vKw8F3MU2Tiz1DAC5aWkzn4CiWcQ6xmfxEcBFsW_Oypqr77tYsRRwH8KAPvyoi5FiyPRKAeFWAnxiSuX75cFvyxtd_WTOe_dzK2fUHBs7GaO7GnscM321ZC3oz_O7lMTNAZW3bMoli0phcFEhqDJB-l4zpGO9_YV4swCTzkz4yLRtUSXCVycppTqkaA6s0buXjUc_ZRQizLT8MQPgw1ZR539TXZFAznenjiQA10lZmkOgj8aNX55w9cTgA_tX4TlSmdnTiagKQnj-d-IEr6rUvhdnVeH-MfqJXgShOQR9vD9CXvwq_uuf4LB5G2d5Wl63KMVUZnpf14LDTKGX_6Ark7iEALNHvbBPHN0Z2OPxPki3TqlIUQ0Z2lAWnh13Qc6MwzPwhjy6i8Q0TQVE9eTe8GXzLM9iX0dxzT0uqC13lKEFa9t3rwZZF_6NwPOSxctWDn89eoonrclDxDoODRO4ajI57IzJAJqunZeJ-lsduHhXDcwQN1V-lJWL_iUbPbZ35EdTDxp9ZDY6jkZyH-yTQ7Xjiy4HDn45TDqY0lkur7oF2DglxczMjDbPQAOwwlpn_dPhgkHuQc-1mcCw996XTM553yDyFqyszvVN1Z91eky7xIzsV9nS4CBwNRx9ry44OYqo1zbz3efCNBKY2BhgIqlDNREzuDKzynstvLTusPE8a1phBjZiyHDWtUSqTO3PibqB0SPS-uap3GQ_rppfIIZagItXDZ91DIDE7zQ3nOhAeCe3-NMfi2aUpt_z0Z55oV_qXV-4NlYWv2j8zhGSufFs05KqDgJpejtx-96G-4q59ZpgmFcEc_G5h_lPaw8F8-ez5XPauF7Ahz_1JozW2PP2Ldq8UZKTWw8050_BNOx2tMv61G-dn6kApkPipqTJBLT71YSvXbR_WoFAtUE3nCC47C9hBCf6nDMjrxYhGnywiwpqWZ-KqTM9xj1yGtDhLfNVa7VNkoqpU4SoWOvYp-sHK-ATKQp3g3oYBDdkk77iPDEFjkRox2dAKdVY3T8Ror_paxh181rBWTGU2RV9sYMFin6b-yjKKsy1taoAv5SAckZAx_xEj5hO6etpVvscp06vFcZOIRVAkVAHAwKPsMHQ8JSalwGUzKYVZMpS_N9HbV5ChFr5p_vD8WjPuWzMkkvNUQQguUnKMZVy689p7sCAZ4Zc0cQn679xTc1gh3HbXzwmcput3bD5Fmnv_hwuhRyAMf-FWl8QCxyz2NKwU0RPA1L5qMVsbSRgL74yH-zxtTqQYrK2Goy1frnMCKwP_Um4NH8efs1SvX6tKwmBluL149YKzVCgDVytB6T-fKyg5Ldxq0cFtkt1VE5qw1tsda7WcR5n4HNlhe8KXoWRKEPJA68HyqOkrKuuhChBZtmbLmqX69OH5EJuDgRHGQHBoPS1E28r6x_dLAnvWwF8k-osOItQ6ghzbqt8AXdcCIeO9rU-nTaXUo-PeaBuLcX-BlQ636z9JzuBzakiFcnKeg99xTvDMRM9vjuNpv92RMPgZeeJcMtLQQwtbHuZsU07KbY7y6kNjMMIW1gapnJuZ5Hp81Z3tW-rXA2aOA_PYyU5iGhoxp-R2j_ZvRCEcslisKAYR6Be0HbzokMz-2OMEtrUecaaVwnCzcStobTUvagCLUv_m6LNlizvirsRHcTeM1pClnBuloEN0SETU-TIsJBGTZ9Qcc3tdgPfa_85POFvO_A-GFjMnkagHpVYd8MLHErXzw9nMkIfwqgafH1Eb5qnCQueCHdmeOngBJG7jFLmqgqHODXWdjZD19BEEgrhhmhUkauoCXiccc1GielG-EwQByNz8d-iXaDNs2uhO8yqE6xAYJZ4YMKwIiaZ9GYOQ2UUt11j3Bi8sM7xt-D-M-T3go_YM3fkXWiy8hIC1Vuvo62QhsykJDcHIl7hatqTTqgvhmUUKOEgukqzUCMkSR1lPBjuHCtDx8UYsatY2G0JAQA-iVy18y9FqSEB13IxISyEEfZT-P7dp5gWhqfb7gDFkqaMs6G_SCE4LkRBEx6dhYraPrH5mwfqrYSK8P5J8VU3tLtDxCz0XLRPylfWBESdMZxqozAyFL2KFsgTApDR7IIPBW2TK17bsSXOi-Vw_w_wEA5duBgNoqFjtsCRh91tmiOlv_JbyoHiKnQNfG_itZNzXWp7yKvCpxbT93nNHl8G7HF-CnG0rhh85xGcogSZqn0xzEaupJq4n0n6XORDrNoCDIhMRO6Kn_QoG3l4sZD_fbTTcS5IFvIStHZws6eB_DVzTkWnJv0LgwPtiLlXjSxUgwtaaRIs69tlid4B0YrMCb-XRcv3ko6Mg0QECrUSnbm8a2McRS8W7iOE1lEqz_VoUasGBMlxazgbVGl54EP-by9Qldrzm7vgN4BF2yplKqBl1zBgKoJ_JaZmRi-UnfQQbThfav3Ofy_XW1-H5FUwH_9DV_ztUi7-YlGK25lZyt3ScE3udtB7z9xXmS_JoX1VSzrrRngKpoZl2bNDUowpoLTW180cSrwCZn9OELez455I5XWJ_KiyiF3gJ8yrWpiK8tdhUdFQrf7v3u69hoW9UZAqg-PeP0L8dUwpne0tY1azxNoh2XjvxYXACJzdYSUZtyID7rvZnM4iH8XwXNEF8Hm_hxF9i0Xb2MeVM89vTYygqjUeYRaZAZWCplXxGbQqn7KWY8dXV9NvjB_iALF4D8qcerUQsdxnusZBAzTtueEmY1GPAY6dKQhBPLLD3JIOPCatc0e50WcxJeNy0XOAt2W4Kxf-MVw00nnNQ1zMghcaat2m_orlCYLZcq7Ay7Md0VL4HAaW2DaHq-j9mJYa7B2x5Rf4fGaGmWcXVPm_BB7uRxfzO6oYyfN-oW972nFFRFQpbBlzT04_9gzYV2GJR0stD1hR70Iq2RNp3aRXfyx5K81iPRPndl5_T4WAMBM21BEF2Ub-VtCGqFSzANHLn6ENL8tUpWTMYwO0Vfg8tQ_5YCLqJVin2h1HBGbt26ql8oB7aBeUF5sOd2ip9K_JbfLKEFY40tsIAIPy1QB6xvZv2pkenGiU2kDjuyxuune_jJnB4PvhsHtqntpuy1Mk0zIjaOhUWt0tg8uhqvF-Pgr-3wichY4v438KtM8n90objVrgxbvXQI9E7QgK_0C9W5uZFUttO9D18PrkMfZ1aiV4ml24-uWvd03Nlv2YG7m2wM98igzH_O1SANbsvvcYB_qvZucsWSu08dP5PASRIKwp48SQeq3GSff8sL3-EWZ8rN0Fs8U6hNkU0ftsqJWDqNBvWNxgZ6oEjeiS6SOPZqtDVG3RkChmuIvdRvWp0av2bpnKKj1WfN5sg3F_lRPjK7qK4hK1VA1V-rNnbpLxlxEEdoyN5dvG5PiUME4Fo_32IU5aaemoYaZOphc7jUxJ-I54Dj1D_TOuN7LacisD_cVNjirLDonf4PmiSfLPMknKkfzewyq9hgjzxGcPmPi7EUTBaemI601lz2alGhNGtCSSV3kMJTW-qDPhNi0wjHLvQcGgH-r4afhHL6KzvfYSCEURtXXzIUpndjkf4PTmEPSCS1S4vYoYLi__mhH1Y4eiaIHwUudqnfTLOY_UDVPUX7b1h6YWWRVc3RJbj9Z2aExqjn_7LR-ld1OwdZctq27JHd_ymDm8-Coj6ZfMbe__E6rl9HczSB8e9z0SuRYNz9iYCar1svBtP-htv79rTZUb4Mf1pcXFkJ64dAW7_djMKFLwP81Hfz5g5bmjtFzkzxyorHv3lvxPuLbqFfH8broWrKseYXYMNr-EYiIITsgXp3yGDG_3c2hyXZfXTq1uAodps4RiqazX8jQ26JJL2GqQSrgJCfHcf-BMhTJV2LxwXH8yGWP1A4_ikZxAMdtYjabr_bsx-lNB4iv1qw5gF1H0O9yhsmKlAMSHuvpL_GBqABQIDFVfzExNVLvo3iyxBXFLcnKaj1yuYa4RNe9VhN4ZtaeG5KFQLlVCpYKyMowhUBMrmqTRJo9-gw9PFK7g42c-kcffi6Nw5_ARRGEebZm_r-kiabOt-iJuqrl9_YkECAQOpIrEZqV5y6NIx-qYTUwh_nGZQz5AmalrG9IJ5WIgs2502Fp8bt2e8f0kzbp3TKWGsIui8cLozJM3AnwP-UV0_xnmkPpDhyrrgQQ9PdnOU2wlDGjfOr0i-XUeI0biJuBdQ-153y4m5MkWikzb7_x_A5MisnbNsgTMAAdVVlyqP9rmbC42pGkNr0bkmEkkGZE31-apus59loyBHekUZFHZD7Q2Aqsr6BC6ll-G6BOTHmUA8VRG-_vLzVJhcK5TYw4OQEp5zYDfU1-6wHA_7HeRy9oTYj9S9COiOFMrS7uDmaIJbdHt9lSJe3sBplGjyx_8RZcufMxA1THsXYd3g5upYhO0KP4suZkB42JkXEUal6N-1xI7h4A_Mspb_Rg7AnQyh9XqraCrPD1MPeobmR7iGqBRZiUdhGJqjCXwJkJjphXJaqNpOqpWTwFVfUh00pENWXe2jjSAs-U_uYFVNXWIreN3_5VpDADrMrknEBX2LVJbe2OvZZtwK8SNC8NaFEYPX-qQ3GjGrJY4FFQuhhDtpf_k6p5Qbi4uW4pzn_FJqWR1eEwv1IiNpDOQD-ts6Jcy-7yZapFFqtsMH5bZrgkApVRUSc59ZJnpK-ENYBYH4BzveXFzJwjFtssUBZsayB4ZEDw8yK0X5CaZIa9jWjr2AWJcwnB8mt8HCp_JkDJ_NqD8CUUGJh1y7HLbAvjy_hgxauxKvKV8iFYyxZUAeVO4eMGfdfNwfUgQF5nXzgJcxruOaNzHOj56P8QoPbKbQ3QxPHgUqteTWrZ74xjqIDQKWWb1szIEWnFI5kKRoK-37ZkRH92D8GCfnYP1dUfUmV9CekXbYNS40WLuH1YAW9Z4Oqg-BGtrBlTyUTu8JNOmBV3cjTOiKzgloacHdBqY_EOngwlea4lZfBW19RNvYzaWdLkovzZZtY1wj0-HS_gD609OPmx74K3cA==",
                "id": "rs_04026b5d3adc19160169092aeaa2f48190a510a76c63197bfb",
                "format": "openai-responses-v1",
                "index": 0
              }
            ]
          },
          "native_finish_reason": "completed"
        }
      ],
      "created": 1762208490,
      "model": "openai/gpt-5-mini",
      "object": "chat.completion",
      "service_tier": null,
      "system_fingerprint": null,
      "usage": {
        "completion_tokens": 1061,
        "prompt_tokens": 290,
        "total_tokens": 1351,
        "completion_tokens_details": {
          "accepted_prediction_tokens": null,
          "audio_tokens": null,
          "reasoning_tokens": 896,
          "rejected_prediction_tokens": null,
          "image_tokens": 0
        },
        "prompt_tokens_details": {
          "audio_tokens": 0,
          "cached_tokens": 0
        },
        "cost": 0.0021945,
        "is_byok": false,
        "cost_details": {
          "upstream_inference_cost": null,
          "upstream_inference_prompt_cost": 7.25e-05,
          "upstream_inference_completions_cost": 0.002122
        }
      },
      "provider": "OpenAI"
    }
  },
  {
    "request": {
      "base_url": "https://openrouter.ai/api/v1",
      "model": "openai/gpt-5-mini",
      "messages": [
        {
          "role": "user",
          "content": "A 20-year-old African American woman came to the clinic with a complaint of persistent fatigue and unintentional weight loss. She has a mole on her back that has been darkening and increasing in size over the past few months. It has an irregular border and is now slightly raised. She noticed a new, dark spots on her arms and chest, which weren't there before. She reports a recent dull ache in her right hip, shortness of breath, and chest discomfort. She has felt increasing fatigue and noticed swelling in her legs and abdomen. Physical exam reveals muffled heart sounds and jugular venous distention. Fluid analyses after pericardiocentesis reveal malignant cells, high protein and LDH level. What is the next best step in the management of this patient? \n\n\nAnswer Choices:\nA. Prescribe meloxicam to manage the persistent fatigue \nB. Prescribe low-dose analgesia \nC. None of the choices\nD. Chemotherapy to kill the malignant cells \nE. Immunosuppression \nF. Rapid antibiotic infusion\nG. Radiotherapy to treat the malignant cells. \nH. Diuretics to reduce the fluid overload "
        }
      ],
      "reasoning_effort": "medium",
      "response_format": {
        "type": "json_schema",
        "json_schema": {
          "name": "answer",
          "strict": true,
          "schema": {
            "type": "object",
            "properties": {
              "answer": {
                "type": "string"
              },
              "answer_letter": {
                "type": "string",
                "enum": [
                  "A",
                  "B",
                  "C",
                  "D",
                  "E",
                  "F",
                  "G",
                  "H"
                ]
              }
            },
            "required": [
              "answer",
              "answer_letter"
            ],
            "additionalProperties": false
          }
        }
      },
      "usage": {
        "include": true
      }
    },
    "response": {
      "id": "gen-1762208490-SB5fUMzyF7EPqPypCakE",
      "choices": [
        {
          "finish_reason": "stop",
          "index": 0,
          "logprobs": null,
          "message": {
            "content": "{\"answer\":\"D. Chemotherapy to treat the malignant cells is the best next step. This patient has metastatic melanoma with a malignant pericardial effusion causing tamponade (muffled heart sounds, JVD); pericardiocentesis has confirmed malignant cells. After urgent drainage, definitive management is treatment of the underlying malignancy (systemic therapy). If effusions recur, surgical options (pericardial window) or intrapericardial sclerotherapy can be used. (Note: modern treatment of metastatic melanoma often uses systemic immunotherapy or targeted therapy when appropriate, but among the options given, chemotherapy/systemic oncologic therapy is the correct choice.)\",\"answer_letter\":\"D\"}",
            "refusal": null,
            "role": "assistant",
            "annotations": null,
            "audio": null,
            "function_call": null,
            "tool_calls": null,
            "reasoning": "**Evaluating treatment options**\n\nI'm considering treatment options for malignant cells in the context of melanoma. Chemotherapy could kill these cells, but immunosuppression and antibiotics aren't applicable here. Radiotherapy might help with localized metastasis, but systemic metastatic melanoma is better treated with immunotherapy. Also, diuretics wouldn't help in this acute situation. The next step after pericardiocentesis is treating the underlying malignancy with chemotherapy, which is historically more effective than chemotherapy alone in melanoma treatment. So, option D seems best.**Formulating the rationale**\n\nI'm providing a rationale for treating malignant pericardial effusion due to metastatic melanoma. The next step involves systemic therapy, which includes chemotherapy or immunotherapy. I might also mention a pericardial window option if there\u2019s a recurrence. My decision is to select option D. I'll compose a concise final JSON that explains the answer. Immediate management includes the already performed pericardiocentesis, and if effusion recurs, a pericardial window can be considered.",
            "reasoning_details": [
              {
                "type": "reasoning.summary",
                "summary": "**Evaluating treatment options**\n\nI'm considering treatment options for malignant cells in the context of melanoma. Chemotherapy could kill these cells, but immunosuppression and antibiotics aren't applicable here. Radiotherapy might help with localized metastasis, but systemic metastatic melanoma is better treated with immunotherapy. Also, diuretics wouldn't help in this acute situation. The next step after pericardiocentesis is treating the underlying malignancy with chemotherapy, which is historically more effective than chemotherapy alone in melanoma treatment. So, option D seems best.**Formulating the rationale**\n\nI'm providing a rationale for treating malignant pericardial effusion due to metastatic melanoma. The next step involves systemic therapy, which includes chemotherapy or immunotherapy. I might also mention a pericardial window option if there\u2019s a recurrence. My decision is to select option D. I'll compose a concise final JSON that explains the answer. Immediate management includes the already performed pericardiocentesis, and if effusion recurs, a pericardial window can be considered.",
                "format": "openai-responses-v1",
                "index": 0
              },
              {
                "type": "reasoning.encrypted",
                "data": "gAAAAABpCSr6z5xN43xkQEg3Qw6UwdOxpByS3lVU3_PRIEtsEy57-yhotKL6FiGURAEhccVnLGkSM5MOUlUu2DQUtx1yFi6hDXdmel2WwzTJU6ECriwx4jBieiqrvlQJl4U6u3Bwl-l5hdPE5ltBp5VetV8eLGdmKsiKJbzAY5a6OOxEp6D_xRb-q9LBWpDczpnUZboe-aEz4W8nFFW7rU5ANg7VP0YTRkupYZQHckAwkOf_ZTDA98sNGkx-ChrYoPH7q2DXTh7HjowVcusq2dElFwLNTHnA58Hv2Tnx0pCTu3VHl5UR0Lnl8UWAzuZ5_D8XEDs5Y_5uUla4YIceA7K-Eamr0e1rdjpiVEYTcGInFjZ1obuyR_4bKwd1k-K8sMFKnqU2vhtDYJoZXy-w7IUcnqk2K1n75Uw30fKynhY4U5nkujKX-9QzM0X0M6Ok9ZaBz4Xqm42K79dPpVd8V3JEjtsXBeu86nMIUqat5ExWUXJUV-ZqzQznY2Gk_EX1a2hxxX7WOLDjXSEWvrot9TfRJrUkPOAbKI6tcEW7SxHCHdBVyYL_ep6BpzdN8hNS_o6vFYSe2PcDvlrGGR4cyh65sPmp_4m9ZhO5IA7zYiRiJ9hTm9l_P7Cv21x62SKQxarVcD0FZXp19DbUtMZmIyNf5B20qfwh8UTfqxJMvn6b5PCzrVz5S1550fSrQeGbO0YU54ji7z1-Xzj63Q3cBwFKxdAJcoACYdw1itaT7ZuOu4OqiB1hVGRA6K2gUFW256Vx4CC5NTpCV9dzuc7cXLIKB_6vhCrG0w9Tc5vxoigTMlRs_MkBumiiPaTW6X5KlprAWa7m9xbbVCkny-hLTjoWF2OG65OVjNwfEYo0SfPervXs0NNqE0DMbQLIJlYj5NSjQb7dH3_wayqMku11AphCWTQKgb26EpizSOvfcATV8srdqq7s7hdmoTz83tR6SZ2pF3bk4rJQ39CFzGwZw8P_uq60z-Jmn8ioI1Bij7sLjABEZOKLM66w0bs-DeEa2TvVpAVq3ufa7-X3RkWczOVRTnDbBD2vSVhUBYfFIuIa_rZRUwmZ4P9pgZvZZkeQpohllO8L0sQftWZlh6vub9sRxf5pSIs0qgAHj3LoMrKtYkQhhrKcrLIOcAxb366FBRAbSMAyUTdl2rDbd5034oVmB9zWvKMdqGmmftgYLoXZMEfnfZDpbVWy25Id7-40vtuQZNgQX1d7QPjYd9CkAfu5mhLys1X1QI2tAVkfcsnOjKWDtX3hU0971B0TfmipZ1oa_dvCMZLDiz0Yaf0nBzv2xfiLN4ubXwDPSdm1hVW7Y9yUcSBaCmK7LUH1x2UvC1DApyk-W8ruvMNRvilLgNcxhlXk0LGShsZ8ZM3nS01d7x22GD4CtgquOLppiBd61irVmxdfsGRqtkTURPN8wvadxDZUIx86SJrO1teu9zpc_h6iLRJp7iXsX78yRKjOXDw2atk2f4-0sX88BInE_8Fl8uWOem6TtvVjryeX_Tis-Sl24TyAMVRTepf2nW58zZ1vCLxgCfsIR4qcaZsCRyvKNI5v67s7oBTIsNo7L4onGrJWjpYdKilTgNuNUTLjaMQ-GWL6yg2Aiv3yd2rXyyNaachvPMO-Enh6Z5KKShW9XfKO7n4KA8hyk2WVQv00Z8CuluAciVzUm_8VzfVdjlaMLn_zm85BsfqOUpSUYpywhgzhH3b-HBv33pIqLk4xJeh8lUT62VNGxonvXRNetpWwRg9EXxs1DPUk_QVDM3T3NE0aFRUvxh3P8SGr4ZqaOG2AnqtS1Nh3j-7HLhDWXZQHw1G_ergwJ5orSyiStliI6w2ANIyAwZQPJLLX6S0rviAegWGyuUaw4vEW8ZRLhV43mqPqWa3v9LWnRGKMhaFyavs4z9Y-TjYVw7k5CakkPpmYL4w1DpDgZ6pZ3ijB3cKNv6Q-0hOR12diDH4Z8GlR61m5gjC3AgkT_PAmkVpvdC4sU67Y-vgWQUwE2QMfDhjpdzQ4ZE9tmITOgKP6lJb37Qh5A9-7n6EEGi6g7fsWvIGaBQ94p-4M2PSpkCKbCs7ww4YT6TLw2aOAzUncYKhahu2GA53oN5YzaGhIY2RYGj_MUKZzrGdgANsc94TjP3T8dBPOM7wSjKnNDj6tZkkyd6B6bFc1xDYRI7RhSjlGDpav2ChvVkLgdDRGhwuefE0DB_IpSHpvgA9j6n06h9cOOPFHl8rQlpnmy5H7ParJgf2VllpwssQiMiWr5YsqbmDrj61Vbr0XftInWxSMjHJHRn9DS-gh7ZinF2NeGzqsn96vCbRyuGxEzvwqEfit5kaPV1uzVuq3O4tosbsT-kExHlPkmYnHzLs9Ux34nFTqitSZyxgaq1Ozs8ox16TQf3cqLlUGtr8JOZwH86Xv52N94FMwlBR15cbjPKbJ98FB9tYdfocPf-J7oYZFt3MEUvuOgCUy4aFmNo0b7LkLEgyXeGPniotBwKvTbtL0wgcvRhKCUrvXmPGENxLQEao2avCXnk26-O3itut5TcopYj94LIaVRVzuc_-F3_SEizZHY5UFccAmK7hfITtPfM8Fm69gphxegYRywdxB89D5khr3kuWG2VyDF8LtPYwCLVC68njaO62VEmHYx-bSDH1FeN_Bkow3ppmOG8IcL7oeYkwmr-_3wCF3nbSZtDCUm1GPF6qe5TOHTCTHrgb4UJhnPndHYjX4uZoW3a2R_-CY1P2WebDPjWve20G0NtSOBtLWbOg6kyqVDawX5S3ARrZcyn7TyT3NKHTAaI_zaQJogcN8OuCpZwetIGKZSqfW6SiaLfHqFy2Ve9_OTkTPtLzFIpfkg6sRLqm0jIAn9-z4nbqJ10iM1eUxCFZO-LmCrMz2IHoT6zVNuFAeJ5Ga-rMXUXm_NPtLYIUjECCQovsZEOeFM_p37wLo6WVCmaixpBVGzbCnJn8Z9TuH4dtZApIoisSjsjHH9d_Bfq4Sj35KP7gDsxpHty7LfuDrBBn8ymcklobD-mBWUSJdXZHQdjnaaijoILN38ncr9M58iXLECBBH3l3h3gUMa2gr0a_eJkaqcvEmuJAMCI-Vaiydv-VRiRew2HDhwd2F8AbDLoYUKn_kSoCbPzen0EWMKUxkDnvcbnBU3_GUj_nsRUwqLZeCdqxbC2p13HONI1TmDFRR9ui5MJMtt_no9d7Mzwbi5dTktcD4COFOtCd4C7jgYu_x8NFwxJT2DZUT7C8UK4Drw35ZttOHThIe1vJncG2eitQXe3Ai3IfJm9Y6bwvuUM5tM8tuDCSgkXyv9kt8X8DQSR6HZNUFJr4nofs0HOLTYxkEN70twKhvH1gbMrS5MxQIrXB8uebUGxMTUNOlaoPfeQTkbVkTqcV6PQBlqYnSFQGyV_V5W8yUQKaO1krck6Qph-8S6gwWwjYgj_Ahnm6-NQU_2h20ElxJPfKX-TYg3jeEYR4DsQSTuik0VrZTdPwDL6eFnNCIfJCJG-XzCM1zAjsO0xP8-5N_5Tzppn0iuCooOGKJMbgdti5VJUtLy-fRbLZl8QQXjjevmNKjm6h2icRaPFwJeosv5o2rK2LPX1G2UfvaMI_Dyb7QK8LQKtwPo5-J_6e7yq735uzw4xXt0jMNVwn0olLhFaSQmJWm6omDpvASSH79zuBriAVgcSvryJrugGJW8pdh-W7DumeFyGQm514xQGGfOyETsWqJpatpkjld_VyYxq7RVCzJilzCvE3chf6Y64YJQkmdcCWaVtPdeFzLTXJofUcnd60n5wRk2QRprXn1Ge-OeIF5Ijj-7SmhFV5Pq1bz-0MtJTw3GDAEMYCn9r5wwEgJdswfKvJr1_nT7AUKbr3iM87_98QYqLX2UGm4-Y4cfxBEaYJo-pvAQqkpJwR-dyCHxN3jOMZUTk9ECNO2UKm5K3_W13oAxknl1YmtrErxf2NxinY77N4PBb9g4xmjQlzzHf4UpBZFRah_r6BjARJGM9UsFKMAMoEJ5RUiJ8DsJJSBBaqpR9JMuuVIFK_-Zm5FbfrDiQ__z7jTuRc4GOKu6Fukt3fl6b1zIYcEOlIHu-bjB7naBx8w0zk78l69FcMlNwj2DVaPVIJ8JivHaBf65GnG7a0gznaYMGSeM0c1kdraMfvGBOX765ZXDAG7SqJWGWcQRe3bIoJgRCPnR3DwyRkciqzUSobJCtj0FqdRC5aOMBt2RDlFZe1u53NCGbtDe3umXItRUCBGkfIrSvCdb1J10YpKOXBaYhf1rjn3qpbhK8RLm4D7CM8Ho9xBZc06d0XKKxCvH1RWWc4Jk1Kd6FDqGH0-ijMCM9iux-tuIUcsk_Pgh8w7GTqjEswG7ycSKlpOrbbuYoeoDkzN6b0Zvpl9WiiSfLP_qbUHHLbSV3SZi1EeqFTGzvrUZEGnTh4=",
                "id": "rs_05a1ca5623fa28850169092aeada54819085f4542fd3e308ca",
                "format": "openai-responses-v1",
                "index": 0
              }
            ]
          },
          "native_finish_reason": "completed"
        }
      ],
      "created": 1762208490,
      "model": "openai/gpt-5-mini",
      "object": "chat.completion",
      "service_tier": null,
      "system_fingerprint": null,
      "usage": {
        "completion_tokens": 663,
        "prompt_tokens": 290,
        "total_tokens": 953,
        "completion_tokens_details": {
          "accepted_prediction_tokens": null,
          "audio_tokens": null,
          "reasoning_tokens": 512,
          "rejected_prediction_tokens": null,
          "image_tokens": 0
        },
        "prompt_tokens_details": {
          "audio_tokens": 0,
          "cached_tokens": 0
        },
        "cost": 0.0013985,
        "is_byok": false,
        "cost_details": {
          "upstream_inference_cost": null,
          "upstream_inference_prompt_cost": 7.25e-05,
          "upstream_inference_completions_cost": 0.001326
        }
      },
      "provider": "OpenAI"
    }
  }
]